HAVpur is the world’s first and only Virosome adjuvanted, new generation Hepatitis A vaccine. It provides early and long-term protection from Hepatitis A. The unique feature of this vaccine is that it confers immunity the natural way. It does not contain any aluminum compounds (adjuvants), and is therefore gentle on the baby, producing minimal side effects. It is ideal for children and adults, because anyone, irrespective of the social status, is vulnerable to Hepatitis A.
